Compare BELFA & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BELFA | PRGO |
|---|---|---|
| Founded | 1949 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | N/A | 1991 |
| Metric | BELFA | PRGO |
|---|---|---|
| Price | $154.63 | $12.89 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $22.50 |
| AVG Volume (30 Days) | 32.1K | ★ 3.8M |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | 0.16% | ★ 8.83% |
| EPS Growth | ★ 19.52 | N/A |
| EPS | ★ 5.17 | N/A |
| Revenue | $649,376,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $28.52 | N/A |
| Revenue Next Year | $6.49 | N/A |
| P/E Ratio | $29.23 | ★ N/A |
| Revenue Growth | ★ 23.70 | N/A |
| 52 Week Low | $53.95 | $12.17 |
| 52 Week High | $158.32 | $30.93 |
| Indicator | BELFA | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 67.22 | 30.72 |
| Support Level | $146.40 | $12.93 |
| Resistance Level | $158.32 | $13.63 |
| Average True Range (ATR) | 4.51 | 0.45 |
| MACD | 2.18 | 0.24 |
| Stochastic Oscillator | 89.34 | 1.13 |
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.